Pharmaceutical Executive-04-02-2009

Pharmaceutical Executive

Shire Joins with GSK to Promote ADHD Drug

April 01, 2009

0

0

Now that Vyvanse, Shire's innovative ADD drug, has been approved for adults, the company needs help to quickly roll out a complex message to neurologists. Its solution: a partnership that takes advantage of GSK's CNS muscle.

Prescription Abandonment Numbers on the Rise

April 01, 2009

News Analysis

0

0

Compliance woes and stingy insurance providers are walloping the pharmaceutical industry. But now another nuisance is rearing its ugly head, as a high number of patients are ignoring their doctor's orders and dropping their prescriptions on purpose.